Literature DB >> 8437220

A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells.

M A Nash1, M K Meyer, G L Decker, R B Arlinghaus.   

Abstract

Nuclei of cells infected with Moloney murine leukemia virus (MoMuLV) were examined for the presence of gag proteins. This analysis was performed in conjunction with other studies suggesting a possible role for gag proteins in regulating nuclear events relating to processing and/or transport of viral genomic RNA. We detected Pr65gag and a p30-related protein in a nuclear fraction of infected cells. We also found evidence that a highly conserved amino acid sequence, which is shared by p30 and U1 small nuclear ribonucleoprotein 70-kDa protein, is a component of the nuclear targeting sequence for Pr65gag. Immunoelectron microscopy studies with a monoclonal anti-p12 antibody established that approximately 18% of gag-containing proteins of MoMuLV are located in the nucleus. Such gag-containing proteins from a mutant MoMuLV that lacks N-terminal myristic acid had greater affinity for the nucleus, suggesting that fatty acid acylation of Pr65gag plays a role in overcoming the proposed nuclear transport signal. The possible roles that nuclear gag proteins may play in retroviral replication are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437220      PMCID: PMC237504     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The isolation and preliminary characterization of temperature-sensitive transformation mutants of Moloney sarcoma virus.

Authors:  D G Blair; M A Hull; E A Finch
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

2.  RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA.

Authors:  H Fan; D Baltimore
Journal:  J Mol Biol       Date:  1973-10-15       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Biosynthesis of Rauscher leukemia viral proteins.

Authors:  R B Naso; L J Arcement; R B Arlinghaus
Journal:  Cell       Date:  1975-01       Impact factor: 41.582

5.  "gag" polyprotein precursors of Rauscher murine leukemia virus.

Authors:  L J Arcement; W L Karshin; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

6.  S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus.

Authors:  M Nash; N V Brown; J L Wong; R B Arlinghaus; E C Murphy
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Incorporation of lipids into variants of Moloney sarcoma virus which produce gag-mos fusion proteins.

Authors:  G E Gallick; R B Arlinghaus
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

8.  Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA.

Authors:  L S Hwang; J Park; E Gilboa
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

9.  In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid.

Authors:  A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus.

Authors:  B Chesebro; W Britt; L Evans; K Wehrly; J Nishio; M Cloyd
Journal:  Virology       Date:  1983-05       Impact factor: 3.616

View more
  35 in total

1.  Entropic switch regulates myristate exposure in the HIV-1 matrix protein.

Authors:  Chun Tang; Erin Loeliger; Paz Luncsford; Isaac Kinde; Dorothy Beckett; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

2.  CRM1-dependent trafficking of retroviral Gag proteins revisited.

Authors:  Mariju F Baluyot; Sarah A Grosse; Terri D Lyddon; Sanath K Janaka; Marc C Johnson
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  Conserved domains of the Nullo protein required for cell-surface localization and formation of adherens junctions.

Authors:  Christine Hunter; Patricia Sung; Eyal D Schejter; Eric Wieschaus
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

4.  New insights into the nuclear localization of retroviral Gag proteins.

Authors:  Leslie J Parent
Journal:  Nucleus       Date:  2011 Mar-Apr       Impact factor: 4.197

5.  Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein.

Authors:  Lisa Z Scheifele; Eileen P Ryan; Leslie J Parent
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA.

Authors:  Nicole Gudleski; John M Flanagan; Eileen P Ryan; Maria C Bewley; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

7.  Repression of the Chromatin-Tethering Domain of Murine Leukemia Virus p12.

Authors:  Jonathon D Brzezinski; Apexa Modi; Mengdan Liu; Monica J Roth
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

8.  NC-mediated nucleolar localization of retroviral gag proteins.

Authors:  Timothy L Lochmann; Darrin V Bann; Eileen P Ryan; Andrea R Beyer; Annie Mao; Alan Cochrane; Leslie J Parent
Journal:  Virus Res       Date:  2012-10-02       Impact factor: 3.303

9.  Packaging of host mY RNAs by murine leukemia virus may occur early in Y RNA biogenesis.

Authors:  Eric L Garcia; Adewunmi Onafuwa-Nuga; Soyeong Sim; Steven R King; Sandra L Wolin; Alice Telesnitsky
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors.

Authors:  Dai-Tze Wu; Monica J Roth
Journal:  Biomaterials       Date:  2014-07-03       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.